Patients with systemic sclerosis and low CD4 numbers after autologous stem cell transplantation have a favorable outcome

Treatment with high-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (aHSCT) is an intensive treatment option for patients with severe forms of systemic sclerosis (SSc). Even th...

Source: Arthritis Research and Therapy - March 20, 2024 Category: Rheumatology Authors: Ann-Christin Pecher, Reinhild Klein, Ina Koetter, Marieke Wagner, Wichard Vogel, Stefan Wirths, Claudia Lengerke and Joerg Christoph Henes Tags: Research Source Type: research